- Популярные видео
- Авто
- Видео-блоги
- ДТП, аварии
- Для маленьких
- Еда, напитки
- Животные
- Закон и право
- Знаменитости
- Игры
- Искусство
- Комедии
- Красота, мода
- Кулинария, рецепты
- Люди
- Мото
- Музыка
- Мультфильмы
- Наука, технологии
- Новости
- Образование
- Политика
- Праздники
- Приколы
- Природа
- Происшествия
- Путешествия
- Развлечения
- Ржач
- Семья
- Сериалы
- Спорт
- Стиль жизни
- ТВ передачи
- Танцы
- Технологии
- Товары
- Ужасы
- Фильмы
- Шоу-бизнес
- Юмор
Akums: India's Pharma CDMO King | अकुम्स: भारत का फार्मा CDMO किंग
Akums Drugs and Pharmaceuticals Share Analysis | Akums Q4 Results & Share Price Target 2026
In this video, we dive deep into Akums Drugs & Pharmaceuticals Ltd (NSE: AKUMS), India's largest Pharma CDMO. Are the fundamentals strong enough to justify its premium 73x P/E valuation? We analyze their latest Q4 results, the massive $25M/year Zambia government deal, European expansion plans, and the hidden moat of their 49 billion unit capacity.
Plus, we break down the 15-minute chart technicals to see if the crucial ₹513 support level will hold or break. Whether you are a long-term investor or a short-term swing trader, we cover the exact bullish and bearish scenarios. Is Akums a Buy, Sell, or Hold? Watch the full video to find out!
📊 What we cover in this video:
• Akums Company Overview & CDMO Business Model
• Q4 FY26 Financial Results Breakdown
• Key Tailwinds: The Zambia Deal & EU-GMP Certifications
• Valuation Check (Is 73x PE too expensive?)
• Technical Analysis: Price Action, Support & Resistance levels
• Final Verdict & Target Price
🐺 Join the Pack!
If you found this deep dive helpful, help us grow the community:
👍 LIKE this video if you learned something new today.
🔗 SHARE it with a fellow trader who wants to master the markets.
🔔 SUBSCRIBE to WolfOut Traders for more institutional-grade insights.
📧 Contact: wolfout.traders@gmail.com
🐦 X (Twitter): https://x.com/WolfoutTraders
📸 Instagram: https://www.instagram.com/wolfout.traders/
⚠️ DISCLAIMER:
This video is for educational and informational purposes only and does not constitute financial advice. We are NOT SEBI-registered advisors. Equity investments are subject to market risks. Please do your own research or consult a certified financial advisor before making any investment or trading decisions. WolfOut Traders holds no liability for any financial losses incurred.
Hashtags:
#akums #akumsshare #akumssharelatestnews #stockmarketindia #pharmastocks #tradingview #stockanalysis #wolfouttraders #nifty #investing
Видео Akums: India's Pharma CDMO King | अकुम्स: भारत का फार्मा CDMO किंग канала WolfOut Traders
In this video, we dive deep into Akums Drugs & Pharmaceuticals Ltd (NSE: AKUMS), India's largest Pharma CDMO. Are the fundamentals strong enough to justify its premium 73x P/E valuation? We analyze their latest Q4 results, the massive $25M/year Zambia government deal, European expansion plans, and the hidden moat of their 49 billion unit capacity.
Plus, we break down the 15-minute chart technicals to see if the crucial ₹513 support level will hold or break. Whether you are a long-term investor or a short-term swing trader, we cover the exact bullish and bearish scenarios. Is Akums a Buy, Sell, or Hold? Watch the full video to find out!
📊 What we cover in this video:
• Akums Company Overview & CDMO Business Model
• Q4 FY26 Financial Results Breakdown
• Key Tailwinds: The Zambia Deal & EU-GMP Certifications
• Valuation Check (Is 73x PE too expensive?)
• Technical Analysis: Price Action, Support & Resistance levels
• Final Verdict & Target Price
🐺 Join the Pack!
If you found this deep dive helpful, help us grow the community:
👍 LIKE this video if you learned something new today.
🔗 SHARE it with a fellow trader who wants to master the markets.
🔔 SUBSCRIBE to WolfOut Traders for more institutional-grade insights.
📧 Contact: wolfout.traders@gmail.com
🐦 X (Twitter): https://x.com/WolfoutTraders
📸 Instagram: https://www.instagram.com/wolfout.traders/
⚠️ DISCLAIMER:
This video is for educational and informational purposes only and does not constitute financial advice. We are NOT SEBI-registered advisors. Equity investments are subject to market risks. Please do your own research or consult a certified financial advisor before making any investment or trading decisions. WolfOut Traders holds no liability for any financial losses incurred.
Hashtags:
#akums #akumsshare #akumssharelatestnews #stockmarketindia #pharmastocks #tradingview #stockanalysis #wolfouttraders #nifty #investing
Видео Akums: India's Pharma CDMO King | अकुम्स: भारत का फार्मा CDMO किंग канала WolfOut Traders
akums share analysis akums drugs and pharmaceuticals share akums share latest news akums share target akums share price akums q4 results akums stock analysis best pharma stocks 2026 pharma cdmo sector india akums zambia deal akums technical analysis nse akums stock market india swing trading stocks akums fundamental analysis akums ipo share akums results today
Комментарии отсутствуют
Информация о видео
21 мая 2026 г. 14:42:21
00:26:21
Другие видео канала





















